Digitizing the Site Network for Traditional and Decentralized Clinical Trials

The majority of clinical trials will continue to use some elements of a site-based study while testing new approaches including hybrid and decentralized clinical trials.

Traditional (site-based), hybrid and decentralized approaches to research will all require integrated remote access to a network of study sites on a centralized platform in order to maximize success.

Register for this webinar to hear how sites have responded to the move toward hybrid studies, how ready they are for technological changes, what technologies they are implementing, how the regulatory landscape has evolved and what sponsors can do to help their sites succeed.

This webinar will also show real-world case studies from Pfizer and other leading sponsors who are connecting to their study sites remotely on site workflow platforms for remote start-up, remote monitoring, remote site management, remote source data review and remote source data verification.

Featuring research technology, site and sponsor experts, and presenting insights from more than 10,000 study sites in 44 countries collaborating on one platform, site digitization and technology modernization plans can be prepared with first-hand knowledge.

Speakers

Blake Adams, SVP of Marketing, Florence (Moderator)

Blake Adams is Senior Vice President of Marketing for Florence and host of The Next Phase podcast on clinical trial technology innovations. He leads a team at Florence creating content on digital transformation in research operations and speaks at numerous conferences on topics of technology in research.

Message Presenter

Nimita Limaye, Research VP, IDC Health Insights

Dr. Nimita Limaye is a Research VP with IDC Health Insights and provides research-based advisory and consulting services, as well as market analysis on key topics related to R&D strategy and technology in the life sciences industry. She addresses aspects such as the role of digital transformation in discovery research, e-clinical ecosystems, the role of NLP, AI, ML, DL and RPA in transforming drug development, precision medicine, pharma R&D execution and strategic outsourcing models.

Message Presenter

Catherine Gregor, Chief Clinical Trial Officer, Florence

Catherine Gregor, MBA, CCRP, CCRC is the Chief Clinical Trial Officer at Florence, the industry leader in remote connectivity in clinical research with more than 10,000 study sites across 40 countries. She has more than 15 years of experience analyzing and implementing change across back-office research operations for finance, clinical operations, regulatory and health information systems. She has worked in a myriad of community and academic environments. Most recently, she served as the Director of Clinical Research Administration at the Vanderbilt-Ingram Cancer Center.

Message Presenter

Ryan Jones, Chief Executive Officer, Florence

Ryan is CEO of Florence Healthcare. Florence advances clinical research through software — its electronic Investigator Site File (eISF) helps over 10,000 research teams around the world take their day back from paper. Before joining Florence, Ryan was president of Pubget (acquired by the Copyright Clearance Center), a research platform serving clinicians at over 600 hospitals and research institutions worldwide. Ryan joined Pubget from Microsoft’s SharePoint team, where he helped the web’s largest sites make information understandable and accessible with document management technology. Before Microsoft, Ryan analyzed enterprise software investments at Commonwealth Capital Ventures and built technology market strategies at the Yankee Group.

Message Presenter